Floatz logo

METRONIDAZOLE

Mass Screening

Sunil PatelSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Mass Screening cohort.

Asset / SponsorPhaseRating
SODIUM PHOSPHATE
Sunil Patel
N/AD
CEFOXITIN
Sunil Patel
N/AD

Same molecule, other indications

METRONIDAZOLE is also rated in:

Surgical Site InfectionDormant
BBB
Indicative ·
72 / 100
View asset →
colorectal neoplasmDormant
BB
Indicative ·
69 / 100
View asset →
Surgery--ComplicationsDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →